Apeiron Biologics

Developer of tumour targeting antibodies and small molecule immunotherapeutics for the treatment of cancer

placeVienna, Vienna, Austria calendar_todayFounded 2005 groups14 employees language apeiron-biologics.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active.

YearFilings
20261

Investor mix

2 investors on record; lead investors include Vienna Insurance Group.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon